Ronald T. Brown In The News

Medical Xpress
Over the past 50 years, attention deficit/hyperactive disorder — more commonly known as ADHD — has evolved from a little-known condition into arguably the most studied disorder in the field of child psychiatry.
Pharmaceutical Technology
Nonstimulant drugs for attention deficit hyperactivity disorder (ADHD) could address the critical need to mitigate abuse potential.
Business Insider
For parents and guardians, choosing activities for their kids with ADHD can feel challenging.
Las Vegas Review Journal
51³Ô¹ÏºÚÁÏ announced Monday that it has launched a center dedicated to scientific research about brain and neurological diseases such as Alzheimer’s and dementia.
Newswise
The 51³Ô¹ÏºÚÁÏ department of brain health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients who are suffering from Alzheimer’s, dementia and other brain and neurological diseases.
Business Insider
It's estimated that more than 3.5 million children and 1.5 million adults in the US take medication for attention deficit hyperactivity disorder (ADHD).
HealthCentral
While medications treat symptoms of ADHD, researchers are always evaluating non-medication strategies, such as psychotherapy, and complementary health approaches like meditation. We asked the experts to weigh in on these tools and others.
UPI
Millions of American kids with attention-deficit/hyperactivity disorder, or ADHD, may have a genetic vulnerability to the disease, a new study suggests.